Name: #POS 2: Professional Poster Session 2
Start: 2024-06-18T11:15:00-0700
End: 2024-06-18T13:15:00-0700

#POS 2: Professional Poster Session 2

Component Type: Session

Professional and Student Posters provide an opportunity for methodology (“how to”), case study, and research to be presented to a diverse group of scientific professionals who are actively involved in the discovery, development, and lifecycle management of pharmaceuticals, biotechnology, medical devices, and healthcare-related products.

Speakers

Malak Almutairi

Researcher, Saudi Food and Drug Authority, Saudi Arabia

I am a researcher specialized in regulatory research with a master's degree in pharmacy and Pharmaceutical Sciences. I have been working in the SFDA (Saudi Food and Drug Authority) for several years now, and my focus has been on ensuring the safety and efficacy of pharmaceutical products... Read More →

Daniel Alvarez

Principal Medical Director, Health Equity and Inclusive Research (HEIR), Genentech, A Member of the Roche Group, United States

Dr. Daniel Alvarez earned his medical degree from the Institute of Medical Science of Havana, Cuba in 2002 and the University of Costa Rica in 2006. He also holds a master's degree in Science of Pharmaceutical Medicine from Hibernia College, Ireland, in 2016 and a Diploma in Pharmacoeconomics... Read More →

Celeste Amadei

Product Manager, PAK Biosolutions, United States

Cheng Chi Chen

Clinical Reviewer, Center For Drug Evaluation, Taiwan

Cheng Chi Chen, Clinical Reviewer, Division of New Drugs, CDE, Taiwan Cheng Chi Chen has been a Clinical Reviewer in Division of New Drugs at CDE Taiwan for more than 1 years. Cheng Chi Chen is a Pharmacist and holds a Master’s degree in Clinical Pharmacy from National Yang Ming... Read More →

Renata Costa

Specialist, LIBBS FARMACEUTICA, Brazil

Renata Watanabe Costa has a degree in Biomedicine, with a postgraduate degree in Research and Development of Medicines and a Master's in Sciences from the Federal University of Sao Paulo (Brazil). She has 13 years of experience in the pharmaceutical industry in the areas of Medical... Read More →

Samantha Cotter

Safety Evaluator, FDA, United States

Dr. Samantha Cotter is a pharmacist and safety evaluator in the Division of Pharmacovigilance within the Office of Surveillance and Epidemiology at the US Food and Drug Administration (FDA). Samantha has over 20 years of clinical pharmacy experience, and 12 years in research at the... Read More →

Matt D'Ambrosio

Policy Analyst, Duke-Margolis Institute For Health Policy, United States

Matt D'Ambrosio is a policy analyst with the Duke-Margolis Institute for Health Policy's Biomedical Innovation portfolio. He primarily works with the Institute's Real-World Evidence Collaborative--providing support on workstream deliverables and stakeholder engagement. Matt is based... Read More →

Tiffany Dominic

Risk Management Fellow, Pfizer, United States

Tiffany Dominic is a Post-Doctoral Risk Management Fellow at Pfizer, in conjunction with Rutgers University. She graduated with her Doctor of Pharmacy degree in May 2022 from St. John's University College of Pharmacy and Health Sciences. As a risk management fellow, she takes part... Read More →

Pierre Engel

Senior Director Business Development, Centogene Gmbh, Germany

With over 15 years of sales and delivery experience in the field of epidemiology and real world evidence (RWE), I am a passionate leader in healthcare innovation and a trusted partner for global pharma accounts. As a Senior Principal Epidemiology at CENTOGENE, I am responsible for... Read More →

Emily Epstein

Clinical Behavioral Health Specialist, Weill Cornell Medicine, United States

Emily Epstein, LMSW, is a Clinical Behavioral Health Care Specialist at Weill Cornell Medicine's Genetics and Personalized Cancer Prevention Program (GPCP). The GPCP is committed to identifying individuals living at an increased lifetime risk for cancer, conducting research, and creating... Read More →

Samuel Ewusie

Associate Director, Safety Evidence and Science, Bristol-Myers Squibb Company, United States

A registered pharmacist with a PharmD and an MS in Global Clinical and Pharmacovigilance Regulations, experienced in Clinical Drug Safety and Pharmacovigilance, Risk Management including Risk Evaluation and Mitigation Strategy (REMS), Pharmacoepidemiology and Research Data analys... Read More →

Majdi Al Gharsan

Director, Director of Medical Services, Ministry of Defence, Saudi Arabia

Yogesh Gulati

Senior Safety Physician, Soterius, India

Cheryl Hergert

University of Southern California, United States

With over 25 years of experience working with small and large companies, Cheryl is familiar with product development for medical devices, pharmaceuticals, and combination products. Her experience ranges from product feasibility testing to product launch. She has held positions in... Read More →

Hisahiro Ito

Head of Project Management Office, National Cancer Center Japan, Japan

Frank Jaeger

Independent Consultant, Nanodose Therapeutics, United States

Frank Jaeger is an accomplished C-suite leader with over 25 years of biopharmaceutical tenure from seed-stage to large global pharma, in small and large molecules, and from pre-launch to in-market experience. His career spans across R&D, Medical Affairs, Business Development, Commercial... Read More →

Sung Hoon Jung

Professor, The Catholic University of Korea, Korea, Republic of

Sung-Goo Kang

Clinical Professor., St.Vincent's Hospital, The Catholic University of Korea, Korea, Republic of

Sarah Kang

Safety Evaluator, FDA, United States

Sarah Kang is a safety evaluator in the Division of Pharmacovigilance (DPV) within the Office of Surveillance and Epidemiology at the United States Food and Drug Administration in Silver Spring, Maryland. She has over 9 years of experience as a clinical pharmacist and over 8 years... Read More →

Joseph Laudano

Medical Director, IQVIA, United States

Joseph B. Laudano BS Pharm, Pharm D – Medical Director, IQVIA Inc. Joe has over 35 years’ experience in Pharma. Before joining IQVIA, he was VP, Medical Affairs at Pharmaspectra, VP Medical Affairs at Alliqua Biomedical and Senior Director of Medical Affairs & Global Head of Publication... Read More →

Christina Mack

Chief Scientific Officer, Real-World Solutions, IQVIA, United States

Christina Mack is Chief Scientific Officer of IQVIA real world solutions. An epidemiologist and engineer by training, she is responsible for driving scientific and technical innovation that directly impacts patient health. Recognized as a 2023 PharmaVoice100 Honoree, she’s committed... Read More →

Laura Magda

Director of Clinical Trials, SRI International, United States

Andrew Marley

Senior Epidemiologist, Parexel, Spain

Hotaka Maruyama

Division of PharmacoEpidemiology, Office of Pharmacovigilance ?, Pharmaceuticals and Medical Devices Agency (PMDA), Japan

I am a reviewer of pharmacoepidemiology division and have a few years' experience in the office of pharmacovigilance I at Pharmaceuticals and medical devices agency(PMDA).

Timothe Menard

Global Head, Quality Excellence Digital | Bioethics Coach (Data Ethics), F. Hoffmann-La Roche Ltd, Switzerland

Started in drug safety at Merck KGaA, joined Roche as a GCP/PV auditor. Transitioned to analytics; now heads Quality Excellence Digital. Focuses on digital & analytics for core quality deliverables. Co-founded the Inter coMPany quALity Analytics consortium to drive data/quality policy... Read More →

Mehdi Najafzadeh

Senior Director, Medidata AI, United States

Mehdi NajafZadeh, PhD, is Senior Director at Medidata AI. Before joining Medidata AI, he was an Assistant Professor of Medicine in the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, and the... Read More →

Raphael Pareschi

Patient Safety Lead/ Head of Pharmacovigilance Brazil, Roche, Brazil

Raphael has more than 16 years of experience in Pharmacovigilance, beginning at Sanofi Brazil, where he acted in roles of increasing responsibility within local PV organization, responsibilities including oversight of case management, PSUR management and RMP management. Raphael also... Read More →

Izabela Pedro

Clinical Research Associate, Hospital Israelita Albert Einstein, Brazil

Gerd Rippin

Senior Director, Biostatistics, Real-World Solutions, IQVIA, Germany

Dr. Gerd Rippin is a trained statistician, receiving his statistics degree in 1995 from the University of Dortmund, Germany (equivalent to BSc and MSc), and his Dr. of Sciences (equivalent to PhD) in 1999 from the University of Mainz, Germany. Dr. Rippin has worked as a medical statistician... Read More →

Bruna Sampaio

Manager, Data management, Hospital Israelita Albert Einstein, Brazil

Bruna has over 14 years of professional experience with technology and data operations. Working in clinical research for almost 10 years, she is experienced in EDC Systems (first as a system analyst and later as an end-user), data management, and data analytics. Currently, she is... Read More →

Chris Schneiderman

Epidemiologist, Abbvie, United States

Samantha Seepersad-Nayee

AD, Excision Biotherapeutics, United States

Alexandru Socolov

Senior Data Scientist, Medidata Solutions, United States

Alexandru is a Senior Data Scientist at Medidata AI focused on building advanced analytical solutions to make clinical trials safer, cheaper and faster. With the background in operations research, mathematical optimization and machine learning, Alexandru applies newest techniques... Read More →

Hiroya Taniguchi

Department of Clinical Oncology, Aichi Cancer Center Hospital, Japan

Brittin Wagner

Senior Research Scientist, PointClickCare, Canada

Brittin Wagner is Senior Research Scientist at PointClickCare. She holds a PhD is in Sociology, PhD Minor in Social Statistics from the University of Washington, with postdoctoral training in health services research & development. She has a longstanding commitment to measurement... Read More →

Matt Wampole

Director, Solution Consulting, Clarivate, United States

Matt Wampole is the Director of Solution Consulting at Clarivate where he and his team supports clients from discovery to launch of new medical interventions. His 20 years of experience covered a broad range of topics across drug discovery and optimization, clinical trial optimization... Read More →

Susan Watson

Associate Director, Bioethics, Eli Lilly and Company, United States

Susan Briggs Watson, Ph.D. is an Associate Director of Bioethics at Eli Lilly and Company. She received a PhD in clinical psychology from Indiana University-Purdue University at Indianapolis (IUPUI) and completed Georgetown University's Intensive Bioethics Course 38. She has worked... Read More →

Susan Watson

Associate Director, Bioethics, Eli Lilly and Company, United States

Sam Willcox

Section Manager - Large Molecule Bioanalysis, ACM Global Laboratories, United Kingdom

Sam graduated from the University of Hull with a BSc in Human Biology in 2009. Since graduating he has worked for the last 15 years in regulated bioanalysis supporting the drug development industry. Expert in the field of bioanalysis of large molecules via ligand binding assays he... Read More →

Rebecca Williams

Senior Clinical Trials Subject Matter Expert, Essex, Part of Emmes Group, United States

Rebecca Williams, PharmD, MPH, is a Clinical Trials Subject Matter Expert with Essex, Part of Emmes Group. In this role she supports strategic policy and data initiatives with the National Cancer Institute’s Coordinating Center for Clinical Trials. Prior to this role she was the... Read More →

18: Posters, Session

Tags Session

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!